Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key iss...
ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009
Bortezomib based therapies for myeloma
Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
Bortezomib based therapies for myeloma ( Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute )
2 Jul 2009
Therapeutic cancer vaccine significantly prolongs disease-free survival for foll...
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma ( Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA )
2 Jul 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: Cancer stem cells and leukaemia
Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School ...
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
Benefits of azacitidine for treatment of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Benefits of azacitidine for treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Epigenetics of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Innovation in the treatment of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Myelodysplastic syndromes (MDS)
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL...
Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hosp...
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009